Efficacy and Safety of SP-8203 in Patients With Ischemic Stroke Requiring rtPA
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 178 participants.
Also called NCT04479449
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 178 participants
- Registry
-
NCT04479449
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT04479449. Randomized; triple masking; primary purpose treatment. Start 2019-03-18 (actual); primary completion 2020-10-19 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety of SP-8203 in Patients With Ischemic Stroke Requiring rtPA
- Acronym
- SP-8203-2002
- Condition
- Ischemic Stroke
- Intervention (Drug)
- SP-8203
- Intervention (Drug)
- Placebo
- Lead sponsor
- Shin Poong Pharmaceutical Co. Ltd.
Record details
- Record id
cardio:ct-nct04479449- Content hash
5bf4b8bb3dcf92fc5f30123ac8858d71beef9904166c3585eb760d3b967dbba9